Search Results 1191-1200 of 17857 for monoclonal antibody

  1. GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

    ... monoclonal antibody-containing therapy. Note: Relapsed disease is defined as disease that has recurred ≥6 months after completion of therapy. Refractory ...

  2. Clinical trials - Oncology (Medical)

    ... antibody (ANCA) associated vasculitis using ... Monoclonal Proteins by Blood Spot and Saliva ... The purpose of this study is to assess the feasibility and develop ...

  3. The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis - Mayo Clinic

    History of Grade ≥ 3 infusion-associated AEs or hypersensitivity to another monoclonal antibody, or known hypersensitivity to diphenhydramine or acetaminophen ...

  4. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    ... monoclonal antibody * For Cohorts G, H, and I: Has symptomatic ascites or pleural effusion * For Cohort I: Has clinically active diverticulitis, intra ...

  5. HER2-positive breast cancer: What is it? - Mayo Clinic

    Mammogram guidelines: What are they? Mastectomy · Molecular breast imaging · Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by ...

  6. A Study Comparing CAR-T Therapy Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants with Relapsed and Lenalidomide-Refractory Multiple Myeloma - Mayo Clinic

    Serum monoclonal paraprotein (M-protein) level ≥ 1.0 gram per deciliter ... Monoclonal antibody treatment within 21 days. Cytotoxic therapy within 14 ...

  7. Multiple myeloma - Diagnosis and treatment - Mayo Clinic

    Bispecific antibody therapy · Bone marrow ... Other medical conditions you have, especially any plasma conditions, such as monoclonal gammopathy of undetermined ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  9. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Treatment with any monoclonal antibody within 4 weeks of screening; History or evidence of colonic mucosal dysplasia; HIV, hepatitis B, hepatitis C, or ...

  10. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

    ... monoclonal antibodies, including therapeutic antibodies. Patients with the following infectious diseases are excluded: known HIV;; active Hepatitis B ...